Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05664802 · ClinicalTrials.gov registry record · NA

e-HERO: Ending the HIV Epidemic in Rural Oklahoma

A NA study of Human Immunodeficiency Virus (HIV), sponsored by Northern Arizona University.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT05664802 is a NA study of Human Immunodeficiency Virus (HIV) that is actively recruiting participants, run by Northern Arizona University. The registered enrollment target is 200 participants, below the 498-participant average among 18 other Human Immunodeficiency Virus (HIV) trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05664802, a NA study of Human Immunodeficiency Virus (HIV), is actively recruiting participants, sponsored by Northern Arizona University.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to increase HIV and syphilis testing and linkage to care, increase condom use, and promote PrEP uptake among sexual minority men (SMM) and American Indian (AI) men in rural Oklahoma, a state that is an Ending the HIV Epidemic (EHE) priority state. The proposed supplement aims to: refine our preliminary intervention strategy in partnership with a Community Advisory Board (CAB) and rural peer mentors, and to assess feasibility, acceptability, and preliminary impact of the e-HERO intervention.

Interventions

  • BEHAVIORAL e-HERO: Ending the HIV Epidemic in Rural Oklahoma

Study Locations (1)

Arizona

  • Northern Arizona University - Flagstaff

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2022-12-01
Est. Completion 2024-08-30
Phase NA

Sponsor

Northern Arizona University

23 total trials

What the Registry Record Tells You About NCT05664802

The ClinicalTrials.gov registry entry for NCT05664802 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 498-participant average among 18 other Human Immunodeficiency Virus (HIV) trials with a reported enrollment target (60% lower). The listed sponsor is Northern Arizona University, which has 23 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Human Immunodeficiency Virus (HIV) appearing as the primary indexed condition, and to 1 intervention - of which e-HERO: Ending the HIV Epidemic in Rural Oklahoma is the first listed.

NCT05664802 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT05664802 about?

NCT05664802 is a clinical study titled "e-HERO: Ending the HIV Epidemic in Rural Oklahoma". The goal of this study is to increase HIV and syphilis testing and linkage to care, increase condom use, and promote PrEP uptake among sexual minority men (SMM) and American Indian (AI) men in rural Oklahoma, a state that is an Ending the HIV Epidemic (EHE) priority state. The proposed supplement ai...

What is the current status of trial NCT05664802?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2022-12-01. Estimated completion is 2024-08-30.

What conditions does trial NCT05664802 study?

This clinical trial studies the following conditions: Human Immunodeficiency Virus (HIV).

What interventions are being tested in trial NCT05664802?

The interventions under investigation include: e-HERO: Ending the HIV Epidemic in Rural Oklahoma (BEHAVIORAL).

Who is sponsoring clinical trial NCT05664802?

This trial is sponsored by Northern Arizona University, which has 23 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05664802 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Human Immunodeficiency Virus (HIV)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.